![](https://img.medscapestatic.com/vim/live/professional_assets/medscape/images/thumbnail_library/gty_240725_prep_injection_hiv_800x450.jpg)
Twice-Yearly PrEP Gives 'Huge' 100% Protection
Twice-yearly injections are 100% effective in preventing new infections, according to the final results from the PURPOSE 1 trial of lenacapavir. For weeks, the HIV community has been talking about this highly anticipated clinical trial and whether the …